Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on Nivolumab with Drug Combination for Patients with Intermediate Stage Liver Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effectiveness of Durvalumab and Bevacizumab with TACE in Patients with Localized Liver Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of E7386 and Pembrolizumab for Patients with Previously Treated Colorectal Cancer, Melanoma, or Hepatocellular Carcinoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
+3
Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
Not recruiting
Investigated Drugs:
+2
Study of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
+2
Study on the Safety and Effectiveness of 166Holmium Radiation Therapy with Atezolizumab and Bevacizumab for Patients with Non-Resectable Liver Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)
Not recruiting
Investigated Drugs:
Study on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment
Not recruiting
Investigated Diseases:Investigated Drugs: